 | • レポートコード：D005-04958 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、皮膚科薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。皮膚科薬の種類別市場規模（処方箋医薬品、市販薬）、用途別市場規模（にきび、皮膚感染症、乾癬、皮膚炎薬、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer、Amgen、Novartis、Johnson & Johnson、Galderma、Pfizer、Merck、AstraZeneca、GlaxoSmithKline、AbbVie ・地域別グローバル市場分析 2015年-2020年 ・皮膚科薬の北米市場（アメリカ、カナダ、メキシコ） ・皮膚科薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・皮膚科薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・皮膚科薬の南米市場（ブラジル、アルゼンチン） ・皮膚科薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：処方箋医薬品、市販薬 ・用途別分析：にきび、皮膚感染症、乾癬、皮膚炎薬、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Dermatological Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.5% in the forecast period of 2020 to 2025 and will expected to reach USD 29900 million by 2025, from USD 25070 million in 2019.
The Dermatological Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Dermatological Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Dermatological Drugs market has been segmented into
Prescription-Based Drugs
Over-the-Counter Drugs
By Application, Dermatological Drugs has been segmented into:
Acne
Skin Infections
Psoriasis
Dermatitis Drugs
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dermatological Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Dermatological Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dermatological Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Dermatological Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Dermatological Drugs Market Share Analysis
Dermatological Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dermatological Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dermatological Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Dermatological Drugs are:
Bayer
Amgen
Novartis
Johnson & Johnson
Galderma
Pfizer
Merck
AstraZeneca
GlaxoSmithKline
AbbVie
Among other players domestic and global, Dermatological Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dermatological Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatological Drugs, with price, sales, revenue and global market share of Dermatological Drugs in 2018 and 2019.
Chapter 3, the Dermatological Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatological Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Dermatological Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Dermatological Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Dermatological Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dermatological Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Prescription-Based Drugs
1.2.3 Over-the-Counter Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Dermatological Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Acne
1.3.3 Skin Infections
1.3.4 Psoriasis
1.3.5 Dermatitis Drugs
1.3.6 Other
1.4 Overview of Global Dermatological Drugs Market
1.4.1 Global Dermatological Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Amgen SWOT Analysis
2.2.4 Amgen Product and Services
2.2.5 Amgen Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Galderma
2.5.1 Galderma Details
2.5.2 Galderma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Galderma SWOT Analysis
2.5.4 Galderma Product and Services
2.5.5 Galderma Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck SWOT Analysis
2.7.4 Merck Product and Services
2.7.5 Merck Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline SWOT Analysis
2.9.4 GlaxoSmithKline Product and Services
2.9.5 GlaxoSmithKline Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 AbbVie
2.10.1 AbbVie Details
2.10.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 AbbVie SWOT Analysis
2.10.4 AbbVie Product and Services
2.10.5 AbbVie Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Dermatological Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Dermatological Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dermatological Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Dermatological Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Dermatological Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Dermatological Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dermatological Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Dermatological Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Dermatological Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Dermatological Drugs Sales and Growth Rate (2015-2020)
4.5 South America Dermatological Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Dermatological Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Dermatological Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Dermatological Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Dermatological Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Dermatological Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Dermatological Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Dermatological Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Dermatological Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Dermatological Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Dermatological Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Dermatological Drugs Sales and Growth Rate (2015-2020)
6.3 UK Dermatological Drugs Sales and Growth Rate (2015-2020)
6.4 France Dermatological Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Dermatological Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Dermatological Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Dermatological Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Dermatological Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Dermatological Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Dermatological Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Dermatological Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Dermatological Drugs Sales and Growth Rate (2015-2020)
7.5 India Dermatological Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Dermatological Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Dermatological Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Dermatological Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Dermatological Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Dermatological Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Dermatological Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Dermatological Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Dermatological Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Dermatological Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Dermatological Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Dermatological Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Dermatological Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Dermatological Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Dermatological Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Dermatological Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Dermatological Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Dermatological Drugs Price by Type (2015-2020)
11 Global Dermatological Drugs Market Segment by Application
11.1 Global Dermatological Drugs Sales Market Share by Application (2015-2020)
11.2 Global Dermatological Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Dermatological Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Dermatological Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Dermatological Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Dermatological Drugs Market Forecast (2021-2025)
12.2.2 Europe Dermatological Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Dermatological Drugs Market Forecast (2021-2025)
12.2.4 South America Dermatological Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Dermatological Drugs Market Forecast (2021-2025)
12.3 Dermatological Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Dermatological Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Dermatological Drugs Market Share Forecast by Type (2021-2025)
12.4 Dermatological Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Dermatological Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Dermatological Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Dermatological Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Dermatological Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Dermatological Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Dermatological Drugs Major Business
Table 9. Bayer Dermatological Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Bayer SWOT Analysis
Table 11. Bayer Dermatological Drugs Product and Services
Table 12. Bayer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Amgen Basic Information, Manufacturing Base and Competitors
Table 14. Amgen Dermatological Drugs Major Business
Table 15. Amgen Dermatological Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Amgen SWOT Analysis
Table 17. Amgen Dermatological Drugs Product and Services
Table 18. Amgen Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Dermatological Drugs Major Business
Table 21. Novartis Dermatological Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Novartis SWOT Analysis
Table 23. Novartis Dermatological Drugs Product and Services
Table 24. Novartis Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 26. Johnson & Johnson Dermatological Drugs Major Business
Table 27. Johnson & Johnson Dermatological Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Johnson & Johnson SWOT Analysis
Table 29. Johnson & Johnson Dermatological Drugs Product and Services
Table 30. Johnson & Johnson Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Galderma Basic Information, Manufacturing Base and Competitors
Table 32. Galderma Dermatological Drugs Major Business
Table 33. Galderma Dermatological Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Galderma SWOT Analysis
Table 35. Galderma Dermatological Drugs Product and Services
Table 36. Galderma Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer Dermatological Drugs Major Business
Table 39. Pfizer Dermatological Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer Dermatological Drugs Product and Services
Table 42. Pfizer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Merck Basic Information, Manufacturing Base and Competitors
Table 44. Merck Dermatological Drugs Major Business
Table 45. Merck Dermatological Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Merck SWOT Analysis
Table 47. Merck Dermatological Drugs Product and Services
Table 48. Merck Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 50. AstraZeneca Dermatological Drugs Major Business
Table 51. AstraZeneca Dermatological Drugs Total Revenue (USD Million) (2017-2018)
Table 52. AstraZeneca SWOT Analysis
Table 53. AstraZeneca Dermatological Drugs Product and Services
Table 54. AstraZeneca Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 56. GlaxoSmithKline Dermatological Drugs Major Business
Table 57. GlaxoSmithKline Dermatological Drugs Total Revenue (USD Million) (2017-2018)
Table 58. GlaxoSmithKline SWOT Analysis
Table 59. GlaxoSmithKline Dermatological Drugs Product and Services
Table 60. GlaxoSmithKline Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. AbbVie Basic Information, Manufacturing Base and Competitors
Table 62. AbbVie Dermatological Drugs Major Business
Table 63. AbbVie Dermatological Drugs Total Revenue (USD Million) (2017-2018)
Table 64. AbbVie SWOT Analysis
Table 65. AbbVie Dermatological Drugs Product and Services
Table 66. AbbVie Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Dermatological Drugs Sales by Manufacturer (2018-2019) (MT)
Table 68. Global Dermatological Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Dermatological Drugs Sales by Regions (2015-2020) (MT)
Table 70. Global Dermatological Drugs Sales Market Share by Regions (2015-2020)
Table 71. Global Dermatological Drugs Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Dermatological Drugs Sales by Countries (2015-2020) (MT)
Table 73. North America Dermatological Drugs Sales Market Share by Countries (2015-2020)
Table 74. North America Dermatological Drugs Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Dermatological Drugs Revenue Market Share by Countries (2015-2020)
Table 76. Europe Dermatological Drugs Sales by Countries (2015-2020) (MT)
Table 77. Europe Dermatological Drugs Sales Market Share by Countries (2015-2020)
Table 78. Europe Dermatological Drugs Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Dermatological Drugs Sales by Regions (2015-2020) (MT)
Table 80. Asia-Pacific Dermatological Drugs Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Dermatological Drugs Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Dermatological Drugs Sales by Countries (2015-2020) (MT)
Table 83. South America Dermatological Drugs Sales Market Share by Countries (2015-2020)
Table 84. South America Dermatological Drugs Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Dermatological Drugs Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Dermatological Drugs Sales by Countries (2015-2020) (MT)
Table 87. Middle East & Africa Dermatological Drugs Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Dermatological Drugs Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Dermatological Drugs Revenue Market Share by Countries (2015-2020)
Table 90. Global Dermatological Drugs Sales by Type (2015-2020) (MT)
Table 91. Global Dermatological Drugs Sales Share by Type (2015-2020)
Table 92. Global Dermatological Drugs Revenue by Type (2015-2020) (USD Million)
Table 93. Global Dermatological Drugs Revenue Share by Type (2015-2020)
Table 94. Global Dermatological Drugs Sales by Application (2015-2020) (MT)
Table 95. Global Dermatological Drugs Sales Share by Application (2015-2020)
Table 96. Global Dermatological Drugs Sales Forecast by Regions (2021-2025) (MT)
Table 97. Global Dermatological Drugs Market Share Forecast by Regions (2021-2025)
Table 98. Global Dermatological Drugs Sales Forecast by Type (2021-2025) (MT)
Table 99. Global Dermatological Drugs Market Share Forecast by Type (2021-2025)
Table 100. Global Dermatological Drugs Sales Forecast by Application (2021-2025)
Table 101. Global Dermatological Drugs Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Dermatological Drugs Picture
Figure 2. Global Sales Market Share of Dermatological Drugs by Type in 2019
Figure 3. Prescription-Based Drugs Picture
Figure 4. Over-the-Counter Drugs Picture
Figure 5. Dermatological Drugs Sales Market Share by Application in 2018
Figure 6. Acne Picture
Figure 7. Skin Infections Picture
Figure 8. Psoriasis Picture
Figure 9. Dermatitis Drugs Picture
Figure 10. Other Picture
Figure 11. Global Dermatological Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Dermatological Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Dermatological Drugs Sales Market Share by Manufacturer in 2019
Figure 32. Global Dermatological Drugs Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Dermatological Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Dermatological Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 37. Global Dermatological Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Dermatological Drugs Revenue Market Share by Regions (2015-2020)
Figure 39. Global Dermatological Drugs Revenue Market Share by Regions in 2018
Figure 40. North America Dermatological Drugs Sales and Growth Rate (2015-2020)
Figure 41. Europe Dermatological Drugs Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Dermatological Drugs Sales and Growth Rate (2015-2020)
Figure 43. South America Dermatological Drugs Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Dermatological Drugs Sales and Growth Rate (2015-2020)
Figure 45. North America Dermatological Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Dermatological Drugs Sales Market Share by Countries (2015-2020)
Figure 47. North America Dermatological Drugs Sales Market Share by Countries in 2018
Figure 48. North America Dermatological Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Dermatological Drugs Revenue Market Share by Countries in 2018
Figure 50. United States Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 51. Canada Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 52. Mexico Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 53. Europe Dermatological Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Dermatological Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Dermatological Drugs Revenue Market Share by Countries in 2019
Figure 56. Germany Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 57. UK Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 58. France Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 59. Russia Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 60. Italy Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 61. Asia-Pacific Dermatological Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Dermatological Drugs Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Dermatological Drugs Revenue Market Share by Regions 2019
Figure 64. China Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 65. Japan Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 66. Korea Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 67. India Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 68. Southeast Asia Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 69. South America Dermatological Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Dermatological Drugs Sales Market Share by Countries in 2019
Figure 71. South America Dermatological Drugs Revenue Market Share by Countries in 2019
Figure 72. Brazil Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 73. Argentina Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 74. Middle East and Africa Dermatological Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Dermatological Drugs Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Dermatological Drugs Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Dermatological Drugs Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 79. Egypt Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 80. Turkey Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 81. South Africa Dermatological Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 82. Global Dermatological Drugs Sales and Growth Rate (2021-2025) (MT)
Figure 83. Global Dermatological Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Dermatological Drugs Market Forecast (2021-2025) (MT)
Figure 85. Europe Sales Dermatological Drugs Market Forecast (2021-2025) (MT)
Figure 86. Asia-Pacific Sales Dermatological Drugs Market Forecast (2021-2025) (MT)
Figure 87. South America Sales Dermatological Drugs Market Forecast (2021-2025) (MT)
Figure 88. Middle East & Africa Sales Dermatological Drugs Market Forecast (2021-2025) (MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
コリン作動薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cholinergic Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cholinergic Drugs market re…- 抗凝血薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Blood-thinning Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Blood-thinning Drugs mar…
- 下痢止め薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Antidiarrheal Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antidiarrheal Drugs marke…
- 自殺防止薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Suicide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 3696 million by 2025, from USD 3384.6 million in 2019. The Anti-Suicide Drugs …
- 化学療法誘発悪心＆嘔吐（CINV）用薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2…